These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3374659)

  • 1. [Prevention of HLA alloimmunization due to platelet transfusion].
    van Marwijk Kooy M; Brand A; Sintnicolaas K; van Prooijen HC
    Ned Tijdschr Geneeskd; 1988 Apr; 132(17):758-61. PubMed ID: 3374659
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
    Snyder EL
    Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet transfusion therapy: platelet concentrate preparation and storage.
    Lee VS; Tarassenko L; Bellhouse BJ
    J Lab Clin Med; 1988 Apr; 111(4):371-83. PubMed ID: 3280712
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
    Menitove JE; Duquesnoy RJ
    Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
    Yuan Q; Chen X; Cheng L; Zhou CH; Fu XM; Li YP; Wang NH; Wang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):412-20. PubMed ID: 21906451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA alloimmunization with leukocyte concentrates from HLA-matched and HLA-non-matched donors in patients with Hunter's syndrome.
    Kakaiya RM; Greenstein R; Pisciotto P; Slocum SK; Rosen D; Cable RG; Morse EE; Gainey A
    Ann Clin Lab Sci; 1985; 15(5):435-40. PubMed ID: 3933403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion].
    Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y
    Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Earlier detection of HLA alloimmunization in platelet transfusion refractoriness by flow cytometric analysis.
    Sato S; Sakurai T; Yamamoto Y; Maekawa I; Ikeda H
    Transfusion; 2005 Aug; 45(8):1399-401. PubMed ID: 16078932
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
    MacPherson BR; Hammond PB; Maniscalco CA
    Ann Clin Lab Sci; 1986; 16(1):38-44. PubMed ID: 3947028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Component therapy.
    Schmidt PJ
    Int Anesthesiol Clin; 1982; 20(4):23-43. PubMed ID: 6816740
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of matched platelet transfusions from unrelated donors.
    Radvany R; Green D; Rossi EC; Draugelis AK; Kahan BD
    Transplant Proc; 1977 Mar; 9(1):513-7. PubMed ID: 867499
    [No Abstract]   [Full Text] [Related]  

  • 18. [The need of a registry of HLA-phenotyped platelet donors].
    Castro Izaguirre E; Muncunill Ribas J
    Med Clin (Barc); 1995 Nov; 105(18):696-9. PubMed ID: 8538251
    [No Abstract]   [Full Text] [Related]  

  • 19. [HLA compatibility and transfusion of a platelet concentrate--a necessary prerequisite for the successful transfusion of platelet concentrates in patients with HLA antibodies].
    Májský A; Korínková P; Vítek A
    Cas Lek Cesk; 1986 Mar; 125(12):363-5. PubMed ID: 3955595
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
    Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
    Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.